Clinical trials are increasingly complex, posing challenges in predicting protocol changes, managing enrollment, and ensuring data quality. Aaron Mackey,...

In this insightful interview, I spoke with Craig Serra, Head, Clinical Research Scientific and Technical Engagement at Flatiron Health,...

Access to healthcare remains a challenge, with limited availability of routine blood testing globally. Truvian Health aims to solve...

A new partnership aims to improve diagnosis and outcomes for Parkinson’s disease and related disorders. The Accelerating Medicines Partnership...

Crescita Therapeutics and NanoPass have entered an exclusive distribution agreement to introduce MicronJetTM600, an advanced intradermal delivery device, to...

COTA, Inc. and Texas Oncology’s Precision Health Informatics (PHI) have forged a collaboration to transform precision medicine within Texas...

The Phase III ARANOTE trial has demonstrated significant benefits for NUBEQA (darolutamide) in combination with androgen deprivation therapy (ADT)...

Decentralized Clinical Trials (DCTs) are revolutionizing clinical research, offering potential improvements in trial efficiency and participant diversity. In a...

Scorpion Therapeutics, a leading oncology company, announced a successful $150 million Series C financing round to advance its precision...

Predicta Biosciences, a company focused on precision oncology, has secured an oversubscribed seed round of $5.2 million. The round...